Suchergebnisse - "Gamalo, Margaret"

PubPharm (4)

1

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata : Phase 2 results from a randomized controlled study

enthalten in: Journal of the American Academy of Dermatology | 2021

von King, B. | Ko, J. | Forman, S. | +9

CommentIn: Dermatol Ther. 2022 Dec;35(12):e15845. - PMID 36124361

2

Baricitinib in patients with moderate-to-severe atopic dermatitis : Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)

enthalten in: Journal of the American Academy of Dermatology | 2021

von Simpson, E. | Forman, S. | Silverberg, J. | +16

3

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis : A Randomized Clinical Trial

enthalten in: JAMA dermatology | 2020

von Reich, K. | Kabashima, K. | Peris, K. | +13

4

Baricitinib in adult patients with moderate-to-severe atopic dermatitis : A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study

enthalten in: Journal of the American Academy of Dermatology | 2019

von Guttman-Yassky, E. | Silverberg, J. | Nemoto, O. | +12

1
[1]